Yan Zhichao, Liao Huanquan, Chen Hongrui, Deng Shuifeng, Jia Yu, Deng Caibin, Lin Jianxian, Ge Jian, Zhuo Yehong
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, People's Republic of China.
Department of Ophthalmology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, People's Republic of China.
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5434-5443. doi: 10.1167/iovs.17-22312.
Recent evidence has suggested a potential association between Alzheimer's disease (AD) and glaucoma and found significant deposition of amyloid-β (Aβ) and Tau protein in the retinas of glaucoma patients. However, no coherent finding has emerged regarding the AD-like changes in the central visual system (CVS). Studies confirming the presence of Aβ and Tau neuropathology are warranted to identify the underlying mechanism that contributes to the visual impairment observed in glaucoma.
A chronic glaucoma model was established in rhesus monkeys. The retina, optic nerve, CVS including the lateral geniculate nucleus (LGN) and primary visual cortex (V1), and cognitive areas including the hippocampus (Hpp) were evaluated. Aβ 1-42 and phosphorylated-Tau (p-Tau) were tested in the aforementioned structure using immunohistochemistry, Western blotting and ELISA, and the neuritic plaques and argyrophilic structures/neurofilaments were observed using silver staining and transmission electron microscopy (TEM).
Immunohistochemistry revealed positive Aβ and p-Tau labeling in the LGN. According to Western blotting assay and ELISA, Aβ and p-Tau were present in the LGN. Aβ also was expressed weakly in the primary visual cortex. In contrast, the hippocampus, which is the most severely affected region in AD, showed no positive labeling. Structurally, silver staining and TEM revealed neuritic plaques and argyrophilic structures/neurofibrillary tangles, in the LGN.
For the first time to our knowledge, these data collectively establish the existence of hallmark AD-like pathologies in the glaucomatous LGN. Our results may provide new targets for developing research therapies that will enhance neuroprotection in glaucoma patients.
最近有证据表明阿尔茨海默病(AD)与青光眼之间可能存在关联,并发现青光眼患者视网膜中存在大量淀粉样β蛋白(Aβ)和 Tau 蛋白沉积。然而,关于中枢视觉系统(CVS)中类似 AD 的变化,尚未出现一致的研究结果。有必要开展研究以证实 Aβ 和 Tau 神经病理学的存在,从而确定导致青光眼患者视力损害的潜在机制。
在恒河猴中建立慢性青光眼模型。对视网膜、视神经、包括外侧膝状体(LGN)和初级视觉皮层(V1)的中枢视觉系统以及包括海马体(Hpp)的认知区域进行评估。使用免疫组织化学、蛋白质免疫印迹法和酶联免疫吸附测定法(ELISA)检测上述结构中的 Aβ1-42 和磷酸化 Tau(p-Tau),并使用银染法和透射电子显微镜(TEM)观察神经炎性斑块和嗜银结构/神经丝。
免疫组织化学显示 LGN 中有阳性 Aβ 和 p-Tau 标记。根据蛋白质免疫印迹分析和 ELISA 结果,LGN 中存在 Aβ 和 p-Tau。Aβ 在初级视觉皮层中也有微弱表达。相比之下,AD 中受影响最严重的海马体未显示阳性标记。在结构上,银染法和 TEM 在 LGN 中发现了神经炎性斑块和嗜银结构/神经纤维缠结。
据我们所知,这些数据首次共同证实了青光眼患者的 LGN 中存在典型的类似 AD 的病理特征。我们的研究结果可能为开发增强青光眼患者神经保护作用的研究性治疗方法提供新的靶点。